焦虑与抑郁对可疑青光眼患者进展为青光眼的影响
该回顾性队列研究从Duke青光眼注册中心提取3259例基线诊断为可疑青光眼的患者,随访平均3.60年,其中911例(28%)进展为青光眼。焦虑和抑郁的患病率分别为32%和33%。焦虑诊断以及焦虑合并抑郁与进展为青光眼的风险显著相关,校正后HR分别为1.16(95%CI 1.01-1.33)和1.27(95%CI 1.07-1.50)。
要点
- 可疑青光眼患者中焦虑和抑郁患病率较高,分别为32%和33%。
- 焦虑诊断与进展为青光眼风险轻度增加相关,校正后HR为1.16。
- 焦虑合并抑郁与进展为青光眼风险相关,校正后HR为1.27。
核心结论
- 可疑青光眼患者中有焦虑史或焦虑合并抑郁史与随访期间进展为青光眼相关。
研究设计与样本
- 回顾性队列研究,从Duke青光眼注册中心提取基线诊断为可疑青光眼的患者3259例,平均随访3.60(2.05)年。
主要发现
- 随访期间911例(28%)诊断为青光眼。
- 焦虑患病率为32%,抑郁患病率为33%。
- 焦虑诊断与进展为青光眼的校正HR为1.16(95%CI 1.01-1.33)。
- 焦虑合并抑郁与进展为青光眼的校正HR为1.27(95%CI 1.07-1.50)。
临床怎么用
- 在评估可疑青光眼患者进展风险时,可关注其焦虑和抑郁病史。
局限性
- 研究为回顾性队列设计,焦虑和抑郁基于电子健康记录编码、病史和问题列表定义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To assess the impact of anxiety and depression in the risk of converting to glaucoma in a cohort of glaucoma suspects followed over time. METHODS: The study included a retrospective cohort of subjects with diagnosis of glaucoma suspect at baseline, extracted from the Duke Glaucoma Registry. The presence of anxiety and depression was defined based on electronic health records billing codes, medical history and problem list. Univariable and multivariable Cox proportional hazards models were used to obtain HRs for the risk of converting to glaucoma over time. Multivariable models were adjusted for age, gender, race, intraocular pressure measurements over time and disease severity at baseline. RESULTS: A total of 3259 glaucoma suspects followed for an average of 3.60 (2.05) years were included in our cohort, of which 911 (28%) were diagnosed with glaucoma during follow-up. Prevalence of anxiety and depression were 32% and 33%, respectively. Diagnoses of anxiety, or concomitant anxiety and depression were significantly associated with risk of converting to glaucoma over time, with adjusted HRs (95% CI) of 1.16 (1.01, 1.33) and 1.27 (1.07, 1.50), respectively. CONCLUSION: A history of anxiety or both anxiety and depression in glaucoma suspects was associated with developing glaucoma during follow-up.
引用
- Berchuck S, Jammal A, Mukherjee S, et al. Impact of anxiety and depression on progression to glaucoma among glaucoma suspects. Br J Ophthalmol. 2020. PMID: 32862132. doi:10.1136/bjophthalmol-2020-316617
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。